A map of Alzheimer's disease-signaling pathways: A hope for drug target discovery

Clinical Pharmacology and Therapeutics

Volumn 93, Issue 5, 2013, Pages 399-401

  Ogishima, S ^a   Mizuno, S ^a   Kikuchi, M ^b   Miyashita, A ^c   Kuwano, R ^c   Tanaka, H ^a,b   Nakaya, J ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; DONEPEZIL; GALANTAMINE; GAMMA SECRETASE; MEMANTINE; MICROTUBULE ASSOCIATED PROTEIN; RIVASTIGMINE; TACRINE;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; GENE MUTATION; GLIA CELL; HUMAN; MICROGLIA; NEUROFIBRILLARY TANGLE; PHENOTYPE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; DRUG DESIGN; DRUG DISCOVERY; HUMANS; MOLECULAR TARGETED THERAPY; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

EID: 84876695136     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2013.37     Document Type: Article

References (5)

1. Kitano, H. A robustness-based approach to systems-oriented drug design. Nat. Rev. Drug Discov. 6, 202-210 (2007).
2. Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D. & Jones, E. Alzheimer's disease. Lancet 377, 1019-1031 (2011).
3. Mizuno, S. et al. AlzPathway: a comprehensive map of signaling pathways of Alzheimer's disease. BMC Syst. Biol. 6, 52 (2012).
4. Funahashi, A., Matsuoka, y., Jouraku, A., Morohashi, M., Kikuchi, N. & Kitano, H. CellDesigner 3.5: a versatile modeling tool for biochemical networks. Proc IEEE 96, 1254-1265 (2008).
5. Matsuoka, y., Ghosh, S., Kikuchi, N. & Kitano, H. Payao: a community platform for SBML pathway model curation. Bioinformatics 26, 1381-1383 (2010).